How Medtech Companies Should Approach the Consumer Health Market

After three decades of working in the medical device space, with stints at leading healthcare companies like Lilly and Medtronic, John Mastrototaro is now setting his sights on digital health and bringing medical-grade technologies to consumers in the form of wearable devices.

There’s a need to collect and leverage data from people remotely and in their homes — a need that is especially useful for patients with chronic conditions, like type 2 diabetes or hypertension.

Data collected from consumer devices give insight into a patient’s health and can identify when someone may need intervention.

That’s where Movano comes in.

John joined Movano in April 2021, knowing he could use his decades of experience in the diabetes and cardiovascular medical device arena to help propel the company’s technology forward.

Movano expects to launch its foundational product, the Movano Ring, in the third quarter of 2022, pending FDA clearance. The smart ring and accompanying app, which are targeted toward women, measures the wearer’s heart rate, heart rate variability (HRV), sleep, respiration rate, temperature, blood oxygen saturation (SpO2), steps, and calories.

With its wearables portfolio, Movano distills health data and insights down for users.

“We want to show people the cause and effect. We want to help them understand how their activities of daily living affect their health metrics, and maybe show how those are improving over time,” John says.

In this episode of Medsider, John explains how digital health technologies can help consumers understand more about their health, give doctors and researchers insight into real-world health data, and how companies can convince payers that the technology is worth the expense.